Rigel Pharmaceuticals (RIGL) Debt Ratio (2019 - 2026)

Rigel Pharmaceuticals' Debt Ratio history runs 8 years deep, the most recent figure standing at 0.15 for Q1 2026.

• In Q1 2026, Debt Ratio fell 56.39% year-over-year to 0.15; the TTM figure through Mar 2026 stood at 0.15 (down 56.39% YoY), while the FY2025 annual figure was 0.1, down 72.02% from the prior year.
• Debt Ratio was 0.15 for Q1 2026 at Rigel Pharmaceuticals, up from 0.1 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.52 in Q3 2023 to a low of 0.1 in Q4 2025.
• Historically, Debt Ratio has averaged 0.35 across 5 years, with a median of 0.34 in 2022.
• The sharpest annual moves came in 2022 and 2025: Debt Ratio jumped 220.19% in 2022, then tumbled 72.02% in 2025.
• A 5-year view of Debt Ratio shows it stood at 0.29 in 2022, then soared by 73.07% to 0.51 in 2023, then slipped by 28.42% to 0.36 in 2024, then sank by 72.02% to 0.1 in 2025, then jumped by 45.43% to 0.15 in 2026.
• The last three Debt Ratio figures came in at 0.15 (Q1 2026), 0.1 (Q4 2025), and 0.25 (Q3 2025), per Business Quant data.